Detalhe da pesquisa
1.
A research center's experience of T-cell redirecting therapies in triple-class refractory multiple myeloma.
Blood Adv
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38717869
2.
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy.
J Clin Oncol
; 42(2): 205-217, 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874957
3.
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy.
Hemasphere
; 8(5): e62, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38774657
4.
Graft versus host disease-related eosinophilic fasciitis: cohort description and literature review.
Adv Rheumatol
; 62(1): 33, 2022 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35999577
5.
Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients.
Blood Cancer J
; 14(1): 83, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38760376